Article

Daily Medication Pearl: Seizalam

Seizalam is a benzodiazepine indicated for the treatment of status epilepticus in adults.

Medication Pearl of the Day: Midazolam injection (Seizalam)

Indication: Seizalam is a benzodiazepine indicated for the treatment of status epilepticus in adults.

Insight:

  • Dosing: Injection: 50 mg/10 mL (5 mg/mL) in a multiple-dose vial.
  • Dosage forms: The recommended dose is 10 mg, administered by intramuscular injection.
  • Adverse events: The most common adverse reactions (incidence >3%) in clinical trials in patients with status epilepticus were upper airway obstruction, agitation, and pyrexia.
  • Mechanism of action: The exact mechanism of action for midazolam in the treatment of status epilepticus is not fully understood but is thought to involve potentiation of GABAergic neurotransmission resulting from binding at the benzodiazepine site of the GABAA receptor.

Source: label (fda.gov)

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com